Corestem is a biopharmaceutical company that researches and commercializes stem cell technology.
Corestem’s research and development is focused on advancing preferred stem cell treatments for intractable disease, driving scientific advancements, and expanding patient care offerings. Corestem is an integrated innovation engine, combining unparalleled scientific expertise, creativity, and mastery of state-of-the art technology, ushering in a new era of a tailored medical products with a suite of new second generation curative stem cell therapies and treatment.
The majority of the advertised stem cell treatments utilize adult stem cells, normally harvested from the patient, and these stem cells are introduced into the damaged part of the body, promoting growth of new tissues and subsequently replacing the diseased tissues. Since the stem cells have been harvested from the body of the patient, the odds of rejection or fatal side effects are very minimal, so stem cell treatments essentially provide a less invasive, more viable, and more sustainable therapeutic or treatment approach.